Lambda Red Recombineering in Escherichia Coli Occurs Through a Fully Single-Stranded Intermediate

Total Page:16

File Type:pdf, Size:1020Kb

Lambda Red Recombineering in Escherichia Coli Occurs Through a Fully Single-Stranded Intermediate Copyright Ó 2010 by the Genetics Society of America DOI: 10.1534/genetics.110.120782 Lambda Red Recombineering in Escherichia coli Occurs Through a Fully Single-Stranded Intermediate J. A. Mosberg,*,†,1,2 M. J. Lajoie*,†,1,2 and G. M. Church* *Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115 and †Program in Chemical Biology, Harvard University, Cambridge, Massachusetts 02138 Manuscript received July 12, 2010 Accepted for publication August 30, 2010 ABSTRACT The phage lambda-derived Red recombination system is a powerful tool for making targeted genetic changes in Escherichia coli, providing a simple and versatile method for generating insertion, deletion, and point mutations on chromosomal, plasmid, or BAC targets. However, despite the common use of this system, the detailed mechanism by which lambda Red mediates double-stranded DNA recombination remains uncertain. Current mechanisms posit a recombination intermediate in which both 59 ends of double-stranded DNA are recessed by l exonuclease, leaving behind 39 overhangs. Here, we propose an alternative in which lambda exonuclease entirely degrades one strand, while leaving the other strand intact as single-stranded DNA. This single-stranded intermediate then recombines via beta recombinase- catalyzed annealing at the replication fork. We support this by showing that single-stranded gene insertion cassettes are recombinogenic and that these cassettes preferentially target the lagging strand during DNA replication. Furthermore, a double-stranded DNA cassette containing multiple internal mismatches shows strand-specific mutations cosegregating roughly 80% of the time. These observations are more consistent with our model than with previously proposed models. Finally, by using phosphorothioate linkages to protect the lagging-targeting strand of a double-stranded DNA cassette, we illustrate how our new mechanistic knowledge can be used to enhance lambda Red recombination frequency. The mechanistic insights revealed by this work may facilitate further improvements to the versatility of lambda Red recombination. VER the past decade, lambda Red recombination 2000), and to develop novel cloning methods (Lee O (‘‘recombineering’’) has been used as a power- et al. 2001; Li and Elledge 2005). Large-scale dsDNA ful technique for making precisely defined insertions, recombineering projects include creating a library of deletions, and point mutations in Escherichia coli, single-gene knockout E. coli strains (Baba et al. 2006) requiring as few as 35 bp of homology on each side and removing 15% of the genomic material from a of the desired alteration (Thomason et al. 2007a; single E. coli strain (Posfai et al. 2006). Linear dsDNA Sharan et al. 2009). With this system, single-stranded recombineering has also been used to insert heterol- DNA (ssDNA) oligonucleotides have been used to ogous genes and entire pathways into the E. coli efficiently modify E. coli chromosomal targets (Ellis chromosome (Zhang et al. 1998; Wang and Pfeifer et al. 2001; Costantino and Court 2003), BACs 2008) and BACs (Lee et al. 2001; Warming et al. 2005), (Swaminathan et al. 2001), and plasmids (Thomason including those used for downstream applications in et al. 2007b), as well as to rapidly optimize a metabolic eukaryotes (Chaveroche et al. 2000; Bouvier and pathway coding for the production of lycopene (Wang Cheng 2009). However, despite the broad use of this et al. 2009). Furthermore, linear double-stranded DNA method, the mechanism of lambda Red recombination (dsDNA) recombineering has been used to replace has not achieved scientific consensus, particularly in chromosomal genes (Murphy 1998; Murphy et al. 2000), the case of dsDNA recombination. A clearer under- to disrupt gene function (Datsenko and Wanner standing of the mechanism underlying this process could suggest ways to improve the functionality, ease, and versatility of lambda Red recombination. Supporting information is available online at http://www.genetics.org/ cgi/content/full/genetics.110.120782/DC1. Three phage-derived lambda Red proteins are neces- Available freely online through the author-supported open access sary for carrying out dsDNA recombination: Gam, Exo, option. and Beta. Gam prevents the degradation of linear 1These authors contributed equally to this work. dsDNA by the E. coli RecBCD and SbcCD nucleases; 2Corresponding authors: Department of Genetics, Harvard Medical lambda exonuclease (Exo) degrades dsDNA in a 59 to School, 77 Avenue Louis Pasteur, New Research Bldg., Room 238, Boston, MA 02115. E-mail: [email protected] and mlajoie@ 39 manner, leaving single-stranded DNA in the recessed fas.harvard.edu regions; and Beta binds to the single-stranded regions Genetics 186: 791–799 (November 2010) 792 J. A. Mosberg, M. J. Lajoie and G. M. Church produced by Exo and facilitates recombination by promoting annealing to the homologous genomic target site (Sawitzke et al. 2007). Current mechanisms claim that Exo binds to both 59 ends of the dsDNA and degrades in both directions simultaneously to produce a double-stranded region flanked on both sides by 39 overhangs (Sharan et al. 2009; Szczepanska 2009). However, a comprehensive explanation of how this construct ultimately recombines with the chromosome has not yet been advanced. Initially, it was proposed that this recombination occurs via strand invasion (Thaler et al. 1987). How- ever, it has more recently been shown that strand invasion is unlikely to be the dominant mechanism in the absence of long regions of homology, as recombi- nation remains highly proficient in a recA- background (Yu et al. 2000). Furthermore, a detailed analysis of lambda Red recombination products showed character- istics consistent with strand annealing rather than a strand invasion model (Stahl et al. 1997). Finally, lambda Red dsDNA recombination has been shown to preferentially target the lagging strand during DNA Figure 1.—Previously proposed lambda Red-mediated replication, which suggests strand annealing rather dsDNA recombination mechanisms. Heterologous dsDNA is than strand invasion (Lim et al. 2008; Poteete 2008). shown in green; Exo is an orange oval, and Beta is a yellow oval. To explain these results, Court et al. (2002) proposed In both mechanisms the recombination intermediate is pro- 9 a strand-annealing model for insertional dsDNA re- posed to be a dsDNA core flanked on either side by 3 ssDNA overhangs. (A) The Court mechanism posits that (1) Beta fa- combination (Figure 1A), in which one single-stranded cilitates annealing of one 39 overhang to the lagging strand 39 end anneals to its homologous target at the replica- of the replication fork. (2) This replication fork then stalls tion fork. The replication fork then stalls, due to the and backtracks so that the leading strand can template switch presence of a large dsDNA nonhomology (i.e., the onto the synthetic dsDNA. The heterologous dsDNA blocks insertion cassette). The stalled replication fork is ulti- further replication from this fork. (3) Once the second repli- cation fork reaches the stalled fork, the other 39 end of the in- mately rescued by the other replication fork traveling tegration cassette is annealed to the lagging strand in the same in the opposite direction around the circular bacterial manner as prior. Finally, the crossover junctions must be re- chromosome. The other 39 end of the recombinogenic solved by unspecified E. coli enzymes (Court et al. 2002). DNA anneals to the homology region exposed by the (B) The Poteete mechanism suggests that (1) Beta facilitates 9 second replication fork, forming a crossover structure, 3 overhang annealing to the lagging strand of the replication fork and (2) positions the invading strand to serve as the new which is then resolved by unspecified E. coli enzymes template for leading-strand synthesis. This structure is resolved (Court et al. 2002). by an unspecified host endonuclease (red triangle), and (3) The Court mechanism was challenged by Poteete the synthetic dsDNA becomes template for both lagging and leading-strand synthesis. A second template switch must then (2008), who showed that the dsDNA recombination of oteete a linear lambda phage chromosome occurs readily onto occur at the other end of the synthetic dsDNA (P 2008). The figure was adapted from the references cited. a unidirectionally replicating plasmid, which does not have the second replication fork required by the Court mechanism (Court et al. 2002). Thus, Poteete pro- While Poteete’s mechanism addresses some of the posed an alternate mechanism (Poteete 2008), termed weaknesses of the Court mechanism, it remains largely ‘‘replisome invasion’’(Figure 1B), in which a 39 overhang speculative. This mechanism does not identify the of the Exo-processed dsDNA first anneals to its comple- endonuclease responsible for resolving the structure mentary sequence on the lagging strand of the recom- after the first template switching event, nor does it bination target. Subsequently, this overhang displaces explain how the recombinogenic DNA and replication the leading strand, thereby serving as the new template machinery form a new replication fork. Additionally, for leading-strand synthesis. The resulting structure is this template-switching mechanism would have to oper- resolved by an unspecified endonuclease, after which ate two times in a well-controlled manner, which may the recombinogenic DNA becomes the template for the not be consistent with the high-recombination frequen- synthesis of both new strands. In
Recommended publications
  • A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations Pentao Liu, Nancy A
    Methods A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations Pentao Liu, Nancy A. Jenkins, and Neal G. Copeland1 Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA Phage-based Escherichia coli homologous recombination systems have recently been developed that now make it possible to subclone or modify DNA cloned into plasmids, BACs, or PACs without the need for restriction enzymes or DNA ligases. This new form of chromosome engineering, termed recombineering, has many different uses for functional genomic studies. Here we describe a new recombineering-based method for generating conditional mouse knockout (cko) mutations. This method uses homologous recombination mediated by the ␭ phage Red proteins, to subclone DNA from BACs into high-copy plasmids by gaprepair,and together with Cre or Flpe recombinases, to introduce loxPorFRT sites into the subcloned DNA. Unlike other methods that use short 45–55-bpregions of homology for recombineering, our metho d uses much longer regions of homology. We also make use of several new E. coli strains, in which the proteins required for recombination are expressed from a defective temperature-sensitive ␭ prophage, and the Cre or Flpe recombinases from an arabinose-inducible promoter. We also describe two new Neo selection cassettes that work well in both E. coli and mouse ES cells. Our method is fast, efficient, and reliable and makes it possible to generate cko-targeting vectors in less than 2 wk. This method should also facilitate the generation of knock-in mutations and transgene constructs, as well as expedite the analysis of regulatory elements and functional domains in or near genes.
    [Show full text]
  • A Homologous Recombination-Based Method of Genetic Engineering
    PROTOCOL Recombineering: a homologous recombination-based method of genetic engineering Shyam K Sharan1, Lynn C Thomason2, Sergey G Kuznetsov1 & Donald L Court3 1Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA. 2SAIC-Frederick Inc., Gene Regulation and Chromosome Biology Laboratory, Basic Research Program, Frederick, Maryland, 21702, USA. 3Gene Regulation and Chromosome Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA. Correspondence should be addressed to S.K.S. ([email protected]) or D.L.C. ([email protected]). Published online 29 January 2009; doi:10.1038/nprot.2008.227 Recombineering is an efficient method of in vivo genetic engineering applicable to chromosomal as well as episomal replicons in Escherichia coli. This method circumvents the need for most standard in vitro cloning techniques. Recombineering allows construction of DNA molecules with precise junctions without constraints being imposed by restriction enzyme site location. Bacteriophage homologous recombination proteins catalyze these recombineering reactions using double- and single-stranded linear DNA substrates, natureprotocols so-called targeting constructs, introduced by electroporation. Gene knockouts, deletions and point mutations are readily made, gene / m tags can be inserted and regions of bacterial artificial chromosomes or the E. coli genome can be subcloned by gene retrieval using o c . recombineering. Most of these constructs can be made within about 1 week’s time. e r u t a n . INTRODUCTION w w Recombineering is an in vivo method of genetic engineering used This protocol will emphasize modification of bacterial artificial w / / 1–5 : primarily in Escherichia coli that uses short 50 base homologies .
    [Show full text]
  • Bacterial Artificial Chromosome Mutagenesis Using Recombineering
    Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2011, Article ID 971296, 10 pages doi:10.1155/2011/971296 Review Article Bacterial Artificial Chromosome Mutagenesis Using Recombineering Kumaran Narayanan1, 2 and Qingwen Chen2 1 Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA 2 School of Science, Monash University, Sunway Campus, Room 2-5-29, Bandar Sunway, 46150, Malaysia Correspondence should be addressed to Kumaran Narayanan, [email protected] Received 2 August 2010; Accepted 21 October 2010 Academic Editor: Masamitsu Yamaguchi Copyright © 2011 K. Narayanan and Q. Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Gene expression from bacterial artificial chromosome (BAC) clones has been demonstrated to facilitate physiologically relevant levels compared to viral and nonviral cDNA vectors. BACs are large enough to transfer intact genes in their native chromosomal setting together with flanking regulatory elements to provide all the signals for correct spatiotemporal gene expression. Until recently, the use of BACs for functional studies has been limited because their large size has inherently presented a major obstacle for introducing modifications using conventional genetic engineering strategies. The development of in vivo homologous recombination strategies based on recombineering in E. coli has helped resolve this problem by enabling facile engineering of high molecular weight BAC DNA without dependence on suitably placed restriction enzymes or cloning steps. These techniques have considerably expanded the possibilities for studying functional genetics using BACs in vitro and in vivo.
    [Show full text]
  • Genetic Engineering Using Homologous Recombination1
    17 Oct 2002 13:49 AR AR174-GE36-14.tex AR174-GE36-14.SGM LaTeX2e(2002/01/18) P1: IBC 10.1146/annurev.genet.36.061102.093104 Annu. Rev. Genet. 2002. 36:361–88 doi: 10.1146/annurev.genet.36.061102.093104 GENETIC ENGINEERING USING HOMOLOGOUS RECOMBINATION1 Donald L. Court, James A. Sawitzke, and Lynn C. Thomason Gene Regulation and Chromosome Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702; e-mail: [email protected], [email protected], [email protected] Key Words DNA replication forks, strand annealing, in vivo cloning, oligo recombination, recombineering ■ Abstract In the past few years, in vivo technologies have emerged that, due to their efficiency and simplicity, may one day replace standard genetic engineering tech- niques. Constructs can be made on plasmids or directly on the Escherichia coli chromo- some from PCR products or synthetic oligonucleotides by homologous recombination. This is possible because bacteriophage-encoded recombination functions efficiently re- combine sequences with homologies as short as 35 to 50 base pairs. This technology, termed recombineering, is providing new ways to modify genes and segments of the chromosome. This review describes not only recombineering and its applications, but also summarizes homologous recombination in E. coli and early uses of homologous recombination to modify the bacterial chromosome. Finally, based on the premise that phage-mediated recombination functions act at replication forks, specific molecular models are
    [Show full text]
  • Improved Bacterial Recombineering by Parallelized Protein Discovery
    Improved bacterial recombineering by parallelized protein discovery Timothy M. Wanniera,1, Akos Nyergesa,b, Helene M. Kuchwaraa, Márton Czikkelyb, Dávid Baloghb, Gabriel T. Filsingera, Nathaniel C. Bordersa, Christopher J. Gregga, Marc J. Lajoiea, Xavier Riosa, Csaba Pálb, and George M. Churcha,1 aDepartment of Genetics, Harvard Medical School, Boston, MA 02115; and bSynthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre, Szeged HU-6726, Hungary Edited by Susan Gottesman, National Institutes of Health, Bethesda, MD, and approved April 17, 2020 (received for review January 30, 2020) Exploiting bacteriophage-derived homologous recombination pro- recombineering, is the molecular mechanism that drives MAGE cesses has enabled precise, multiplex editing of microbial genomes and DIvERGE (4, 32, 33). This method was first described in and the construction of billions of customized genetic variants in a E. coli, and is most commonly promoted by the expression of bet single day. The techniques that enable this, multiplex automated ge- (here referred to as Redβ) from the Red operon of Escherichia nome engineering (MAGE) and directed evolution with random ge- phage λ (5, 6, 34). Redβ is an ssDNA-annealing protein (SSAP) nomic mutations (DIvERGE), are however, currently limited to a whose role in recombineering is to anneal ssDNA to compli- handful of microorganisms for which single-stranded DNA-annealing mentary genomic DNA at the replication fork. Although im- proteins (SSAPs) that promote efficient recombineering have been provements to recombineering efficiency have been made (7–9), identified. Thus, to enable genome-scale engineering in new hosts, the core protein machinery has remained constant, with Redβ efficient SSAPs must first be found.
    [Show full text]
  • Mini-E: a Tractable System for Chromosome and BAC Engineering
    Gene 315 (2003) 63–69 www.elsevier.com/locate/gene Mini-E: a tractable system for chromosome and BAC engineering Donald L. Courta,*, Srividya Swaminathanb, Daiguan Yua, Helen Wilsona, Teresa Bakera, Mikail Bubunenkoa, James Sawitzkea, Shyam K. Sharanb a Molecular Control and Genetics Section, Gene Regulation and Chromosome Biology Laboratory, NCI/FCRDC, National Cancer Institute at Frederick, Building 539/Room 243, P.O. Box B, Frederick, MD 21702, USA b Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, 1050 Boyles Street, Frederick, MD 21702, USA Received 4 March 2003; received in revised form 12 May 2003; accepted 28 May 2003 Received by V. Larionov Abstract The bacteriophage lambda (E) recombination system Red has been used for engineering large DNA fragments cloned into P1 and bacterial artificial chromosomes (BAC or PAC) vectors. So far, this recombination system has been utilized by transferring the BAC or PAC clones into bacterial cells that harbor a defective E prophage. Here we describe the generation of a mini-E DNA that can provide the Red recombination functions and can be easily introduced by electroporation into any E. coli strain, including the DH10B-carrying BACs or PACs. The mini-E DNA integrates into the bacterial chromosome as a defective prophage. In addition, since it retains attachment sites, it can be excised out to cure the cells of the phage DNA. We describe here the use of the mini-E recombination system for BAC modification by introducing a selectable marker into the vector sequence of a BAC clone.
    [Show full text]
  • The Efficiency for Recombineering Is Dependent on the Source of The
    bioRxiv preprint doi: https://doi.org/10.1101/745448; this version posted August 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The efficiency for recombineering is dependent on the source of the 2 phage recombinase function unit 3 Yizhao Chang, a Qian Wang, b Tianyuan Su, a Qingsheng Qia,c # 4 a State Key Laboratory of Microbial Technology, Shandong University, No. 72 Binhai Road, 5 Qingdao 266237, P.R. China 6 7 b National Glycoengineering Center, Shandong University, Jinan, Shandong, China 8 c CAS Key Lab of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess 9 Technology, Chinese Academy of Sciences, Qingdao, Shandong, China 10 11 Running Head: Features affecting recombineering efficiency 12 13 # Address correspondence to Qingsheng Qi, [email protected]. 14 15 Word counts for abstract: 183 16 Word counts for text: 3621 17 18 19 20 bioRxiv preprint doi: https://doi.org/10.1101/745448; this version posted August 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 21 Abstract 22 Phage recombinase function units (PRFUs) such as lambda-Red or Rac RecET have been proven 23 to be powerful genetic tools in the recombineering of Escherichia coli.
    [Show full text]
  • Manipulating the Mouse Genome Using Recombineering
    e in G net ts ic n E e n Biswas and Sharan, Adv Genet Eng 2013, 2:2 g m i e n c e e n DOI: 10.4172/2169-0111.1000108 r a i v n d g A Advancements in Genetic Engineering ISSN: 2169-0111 Review Article Open Access Manipulating the Mouse Genome Using Recombineering Kajal Biswas and Shyam K Sharan* Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA Abstract Genetically engineered mouse models are indispensable for understanding the biological function of genes, understanding the genetic basis of human diseases, and for preclinical testing of novel therapies. Generation of such mouse models has been possible because of our ability to manipulate the mouse genome. Recombineering is a highly efficient, recombination-based method of genetic engineering that has revolutionized our ability to generate mouse models. Since recombineering technology is not dependent on the availability of restriction enzyme recognition sites, it allows us to modify the genome with great precision. It requires homology arms as short as 40 bases for recombination, which makes it relatively easy to generate targeting constructs to insert, change, or delete either a single nucleotide or a DNA fragment several kb in size; insert selectable markers or reporter genes; or add epitope tags to any gene of interest. In this review, we focus on the development of recombineering technology and its application to the generation of genetically engineered mouse models. High-throughput generation of gene targeting vectors, used to construct knockout alleles in mouse embryonic stem cells, is now feasible because of this technology.
    [Show full text]
  • Identification and Analysis of Recombineering Functions from Gram-Negative and Gram-Positive Bacteria and Their Phages
    Identification and analysis of recombineering functions from Gram-negative and Gram-positive bacteria and their phages Simanti Datta, Nina Costantino, Xiaomei Zhou, and Donald L. Court† Gene Regulation and Chromosome Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702 Edited by Sankar Adhya, National Institutes of Health, Bethesda, MD, and approved December 12, 2007 (received for review September 25, 2007) We report the identification and functional analysis of nine genes but linear DNA recombination studies with RecET have used ␭ from Gram-positive and Gram-negative bacteria and their phages Gam to inhibit nucleases (4). that are similar to lambda (␭) bet or Escherichia coli recT. Beta and For recombineering, either a dsDNA PCR product (1, 4, RecT are single-strand DNA annealing proteins, referred to here as 15–17) or an oligonucleotide (oligo) (18–21) carrying short recombinases. Each of the nine other genes when expressed in E. (Ϸ50-bp) segments homologous to the target sequences can be coli carries out oligonucleotide-mediated recombination. To our used. These linear DNA substrates are precisely recombined in knowledge, this is the first study showing single-strand recombi- vivo by the phage proteins to target DNA on any replicon. When nase activity from diverse bacteria. Similar to bet and recT, most of linear dsDNA is used for recombination, both the exonuclease these other recombinases were found to be associated with pu- and single-strand annealing protein are required. For optimal tative exonuclease genes. Beta and RecT in conjunction with their recombination, RecBCD should be inactivated, either by muta- cognate exonucleases carry out recombination of linear double- tion or by ␭ Gam (1, 15, 22).
    [Show full text]
  • Recombineering Using the Modified DH10B Strain DY380
    Recombineering protocol #1 Recombineering using the modified DH10B strain DY380 by Søren Warming, Ph.D. Overview 1. Design primers with 50 bp homology suited for either targeting (insertion of a selectable marker into a specific site) or gap repair (retrieving a piece of DNA into a linear piece of vector backbone). 2. Run PCR and digest residual plasmid template away with DpnI (1-2 ml in a standard 25 ml PCR reaction, @37°C for 1 h). DpnI works fine in PCR buffers. Gel purify the PCR product and elute in ddH2O. If concentration is low, EtOH precipitate and dissolve in small volume of ddH2O. You need 2 x 100-300 ng rather concentrated PCR product per experiment. 3. Alternatively, design primers to amplify “mini-arms” of 250-500 bp length, and clone these arms into an appropiate vector using conventional cloning techniques. The vector is prepared by digestion/linearization and gel purification of the desired band. Background will be higher than with DpnI digested PCR fragments, but the efficiency is very high when the arms are longer. 4. Transform your target plasmid (or BAC) into electrocompetent DY380 cells, see below. Alternatively, co-transform target plasmid and PCR product (see note below). 5. From a single isolated colony, inoculate a 5 ml o/n culture with appropriate selection 6. Perform the heat shock induction, followed by transformation (the recombineering experiment). Transformation (electroporation) of DY380 1. Make a 5 ml o/n culture either from the DY380 freeze stock or from a colony containing a target plasmid. IMPORTANT: Keep the cells @ 32°C or lower.
    [Show full text]
  • Transposon-Mediated BAC Transgenesis in Zebrafish
    PROTOCOL Transposon-mediated BAC transgenesis in zebrafish Maximiliano L Suster1,2, Gembu Abe1, Anders Schouw2 & Koichi Kawakami1,3 1Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan. 2Sars International Center for Marine Molecular Biology, University of Bergen, Bergen, Norway. 3Department of Genetics, Graduate University for Advanced Studies (SOKENDAI), Mishima, Shizuoka, Japan. Correspondence should be addressed to M.L.S. ([email protected]) or K.K. ([email protected]). Published online 1 December 2011; doi:10.1038/nprot.2011.416 Bacterial artificial chromosomes (BACs) are widely used in studies of vertebrate gene regulation and function because they often closely recapitulate the expression patterns of endogenous genes. Here we report a step-by-step protocol for efficient BAC transgenesis in zebrafish using the medaka Tol2 transposon. Using recombineering in Escherichia coli, we introduce the iTol2 cassette in the BAC plasmid backbone, which contains the inverted minimal cis-sequences required for Tol2 transposition, and a reporter gene to replace a target locus in the BAC. Microinjection of the Tol2-BAC and a codon-optimized transposase mRNA into fertilized eggs results in clean integrations in the genome and transmission to the germline at a rate of ~15%. A single person can prepare a dozen constructs within 3 weeks, and obtain transgenic fish within approximately 3–4 months. Our protocol drastically reduces the labor involved in BAC transgenesis and will greatly facilitate biological and biomedical studies in model vertebrates. INTRODUCTION BAC transgenesis has been used extensively in a broad range of appli- BAC concatemers at a single genomic locus; the remaining carry cations in mice, from studies of gene regulation to creating animal between 5 and 48 copies of the BAC in various orientations15.
    [Show full text]
  • MIE Review.Pdf
    [15] recombineering 171 [15] Recombineering: In Vivo Genetic Engineering in E. coli, S. enterica, and Beyond By JAMES A. SAWITZKE,LYNN C. THOMASON,NINA COSTANTINO, MIKHAIL BUBUNENKO,SIMANTI DATTA, and DONALD L. COURT Abstract ‘‘Recombineering,’’ in vivo genetic engineering with short DNA homo- logies, is changing how constructs are made. The methods are simple, precise, efficient, rapid, and inexpensive. Complicated genetic constructs that can be difficult or even impossible to make with in vitro genetic engineering can be created in days with recombineering. DNA molecules that are too large to manipulate with classical techniques are amenable to recombineering. This technology utilizes the phage l homologous recom- bination functions, proteins that can efficiently catalyze recombination between short homologies. Recombineering can be accomplished with linear PCR products or even single‐stranded oligos. In this chapter we discuss methods of and ways to use recombineering. Introduction What Is Recombineering? In vivo genetic engineering using the bacteriophage lambda (l) recom- bination proteins and short DNA homologies has been termed ‘‘recombi- neering’’ (recombination‐mediated genetic engineering)(Ellis et al., 2001) and is the subject of this chapter. Genetic engineering has been instrumental in revolutionizing studies in molecular biology for over 30 years since the discovery of restriction enzymes. Escherichia coli has been the standard host used to recover the products of this in vitro genetic engineering. Since the late 1990s, however, new in vivo technologies have emerged that greatly simplify, accelerate, and expand genetic engineering in E. coli, Salmonella enterica, and other organisms. Now, within a week a researcher can modify any nucleotide(s) of choice in almost any manner.
    [Show full text]